Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Dec;9(12):1351-1353.
doi: 10.1016/S2213-2600(21)00462-8. Epub 2021 Oct 21.

Colchicine treatment in COVID-19: the remaining unsolved question

Affiliations
Comment

Colchicine treatment in COVID-19: the remaining unsolved question

Adriana Rojas-Villarraga et al. Lancet Respir Med. 2021 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

AR-V, RP-M, and AG-L are currently researchers in the Impact of Colchicine in Hospitalized Colombian Patients With COVID-19 (COLCOVID19) clinical trial (ClinicalTrials.gov, NCT04539873). AR-V reports fees for conferences from Abbvie, Amgen, Biopas-UCB, Janssen, and Pfizer; and fees for Advisory Board membership from Alexion. All other authors declare no competing interest.

Comment on

References

    1. Parra-Medina R, Sarmiento-Monroy JC, Rojas-Villarraga A, Garavito E, Montealegre-Gómez G, Gómez-López A. Colchicine as a possible therapeutic option in COVID-19 infection. Clin Rheumatol. 2020;39:2485–2486. - PMC - PubMed
    1. Lien C, Lee M, Weng S, et al. Repurposing colchicine in treating patients with COVID-19: a systematic review and meta-analysis. Life. 2021;11:864. - PMC - PubMed
    1. Tardif J-C, Bouabdallaoui N, L'Allier PL, et al. Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial. Lancet Respir Med. 2021;9:924–932. - PMC - PubMed
    1. RECOVERY Collaborative Group Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet Respir Med. 2021 doi: 10.1016/S2213-2600(21)00435-5. published online Oct 18. - DOI - PMC - PubMed
    1. Scott I. COVID-19 pandemic and the tension between the need to act and the need to know. Intern Med J. 2020;50:904–909. - PMC - PubMed